Brandinium

Trademark search for:

OLIGOSYNT

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2011-06-23 — Application filed
  • 2011-06-27 — Application filed
  • 2011-06-29 — Application filed
  • 2011-10-05 — Assigned to examiner
  • 2011-10-06 — Teas voluntary amendment received
  • 2011-10-13 — Assigned to lie
  • 2011-10-17 — Examiners amendment and/or priority action - completed
  • 2011-10-17 — Notification of examiner's amendment/priority action e-mailed
  • 2011-10-17 — Examiner's amendment/priority action e-mailed
  • 2012-01-03 — Office action issued
  • 2012-01-17 — Examiners amendment -written
  • 2012-01-17 — Approved for pub - principal register
  • 2012-01-17 — Teas/email correspondence entered
  • 2012-01-17 — Examiners amendment e-mailed
  • 2012-01-17 — Notification of examiners amendment e-mailed
  • 2012-01-17 — Examiner's amendment entered
  • 2012-01-17 — Correspondence received in law office
  • 2012-01-23 — Law office publication review completed
  • 2012-02-08 — Notification of notice of publication e-mailed
  • 2012-02-28 — Published for opposition
  • 2012-02-28 — Official gazette publication confirmation e-mailed
  • 2012-05-15 — Registered-principal register
  • 2016-06-08 — Automatic update of assignment of ownership
  • 2017-05-15 — Courtesy reminder - sec. 8 (6-yr) e-mailed
  • 2018-01-17 — Automatic update of assignment of ownership
  • 2018-05-08 — Teas change of correspondence received
  • 2018-05-08 — Teas section 8 & 15 received
  • 2018-05-21 — Case assigned to post registration paralegal
  • 2018-05-21 — Registered - sec. 8 (6-yr) accepted & sec. 15 ack.
  • 2018-05-21 — Notice of acceptance of sec. 8 & 15 - e-mailed
  • 2020-02-13 — Attorney/dom.rep.revoked and/or appointed
  • 2020-02-13 — Teas revoke/app/change addr of atty/dom rep received
  • 2020-09-30 — Automatic update of assignment of ownership
  • 2021-05-15 — Courtesy reminder - sec. 8 (10-yr)/sec. 9 e-mailed
  • 2022-11-25 — Cancelled sec. 8 (10-yr)/expired section 9
  • 2022-11-25 — Final status recorded
  • 2023-10-19 — Attorney/dom.rep.revoked and/or appointed
  • 2023-10-19 — Teas change of domestic representatives address
  • 2023-10-19 — Teas change of owner address received
  • 2023-10-19 — Teas change of correspondence received
  • 2023-10-19 — Applicant/correspondence changes (non-responsive) entered
  • 2023-10-19 — Teas revoke/app/change addr of atty/dom rep received

Owner Information

CYTIVA SWEDEN AB
UPPSALA SE
GE HEALTHCARE BIO-SCIENCES AB
UPPSALA SE
GE HEALTHCARE BIOPROCESS R&D AB
UPPSALA SE
GE Healthcare Bio-Sciences AB
Uppsala SE
GE Healthcare Bio-Sciences AB
Uppsala SE
GE Healthcare Bio-Sciences AB
Uppsala SE

Correspondent

Dyan M. House Baker & McKenzie LLP
1900 N. Pearl Street, Suite 1500
Dallas, TX 75201
United States

Filing Details

Filing Date:
2011-06-23
Status Date:
2022-11-25
Filing Year:
2011

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.